Ipecac alternatives
This article was originally published in The Tan Sheet
Executive Summary
The American Academy of Pediatrics states it is "premature to recommend the administration of activated charcoal" as an alternative to ipecac syrup to treat ingestion of a potentially poisonous substance in a Nov. 3 1policy statement. Charcoal is "poorly accepted by young children" and does not store well in the home, the statement says. However, AAP adds that ipecac should "no longer be used routinely as a home treatment strategy" either. The use of activated charcoal in conjunction with ipecac syrup was discussed at Nonprescription Drugs Advisory Committee's June 2003 meeting on retaining ipecac's current OTC status (2"The Tan Sheet" June 2, 2003, p. 5)...
You may also be interested in...
Ipecac Labeling Should Include Maximum Dose – NDAC Briefing Materials
It would be "useful" for the labeling of ipecac syrup to include "a specific time interval for administering activated charcoal after ipecac ingestion," Center for Drug Evaluation & Research Division of Drug Risk Evaluation Safety Evaluator Lauren Lee states in a post-marketing safety review on the emetic syrup
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.